Alembic Pharma signs deal with Amlan International to bring poultry health solutions to India

Alembic Pharmaceuticals Ltd has entered into a strategic commercial agreement with Amlan International — the animal health business of Oil-Dri Corporation of America — for introducing cutting-edge poultry health solutions to the Indian market.

This collaboration will expand access to advanced feed additives that improve gut health, nutrient absorption, and feed conversion ratio (FCR), ensuring better poultry yields and supporting the industry’s growing demand for high-quality protein. It also establishes a framework for knowledge sharing, technical training, and sustainable growth in India’s poultry sector, stated an official release here on Tuesday.

Shaunak Amin, Managing Director, Alembic Pharmaceuticals Ltd, stated in the release, “At Alembic, we have always believed in driving innovation that creates real impact. Partnering with Amlan International is a step towards that goal, allowing us to bring scientifically backed, practical solutions to poultry farmers across India. With Amlan’s expertise in toxin binder & gut health, and with our strong presence in the market, we’re not just introducing new products, we’re addressing key challenges in poultry farming. Our long term goal is to improve efficiency and contribute towards a more sustainable future for the industry.”

W. Wade Robey, VP of Agriculture, Oil-Dri Corporation of America and President of Amlan International, stated, “This strong foundation of partnership will open the door with innovative and research based products broadly reaching India’s poultry and feed milling sector. It is a pleasure for Amlan International to collaborate with Alembic Pharmaceuticals India that has a strong legacy with a global footprint. This agreement will lay the framework for cultivating success through strong collaboration, continuous learning, knowledge sharing, and an innovative range of products to enhance poultry productivity.”